Microcapfun
I suggested ONCY at 3.00 and it made it to 6.50 aprox. A lot of other people suggest stocks and i dont see you getting on their case. Nor have i ever suggested a medical background, investment background. I hold a small position that i am confortable with - why dont you go after that guy/investment letter that also carries ONCY on their roster... Miller something...how dare somebody suggest a stock that you dont agree with...
Get a life...
I made an investment in ONCY and i promise not to come after you to make up my losses nor does Acuity who holds 16-17% of the company, so give it a rest. I mentioned the stock a few times at critical dates etc
You are trying to discredit me or embarass me...with the quotes below....can i just call you an asshold and be even?
i am not giving my theses in biotech investment, nor do i need to prove to you or anyone else my biotech prowess, nor do i need to get your endorsement or dew's etc - can you get that?
1. Randomized trials are not necessary because we can just compare to historical data - which doesn't change much over the years. pretty sure its my quote
2. Success in animals implies success in humans. [Virtually no drug makes it to Phase I w/o success in animals!] dont think its my quote
3. Success of a somewhat related drug implies success of my company's drug. [But OncoVex, a Herpes simplex type 1 virus *engineered* to not replicate in normal cells and *engineered* to express GM-CSF, is EXTREMELY different than the naturally occuring reovirus!] not my quote
4. If a fund buys a lot of my company, they must know what they are doing; that is evidence my company will succeed. [If you think a fund does better DD than you ... BUY THE FUND!] no thanks, i rather buy the bio co. i heard that some of these funds have phd on staff to give them an edge in selecting stocks. since i have no edge - i choose to consider a rather large position as an added plus - you can do what you want...
5. There is no need for a pivotal Phase 3 trial to be built upon a similar randomized Phase 2. dont think its my quote
6. If the CEO says it - it's true. i do the investing myself - not trusting you, dew or the ceo , and i wont take up your time to explain how much % weight i give to the ceo in my evaluation
7. My company would not have moved into Phase 3 and started preparing for launch if they were not fairly sure of success - and since they're fairly sure, I can be as well. blatant lies made up by you
8. If my company pays a well-known company to manufacture the drug, it is a very good sign. A well-known company wouldn't waste its time with losers. [The key word here is "pays".] typically you have to pay to get something in return and if you want to manufacture a virus you pay one of the best company that has a virology mft capability.
9. If my drug + a standard drug improves the condition of cancer patients, then it is clear that my drug works. it would have to exceed the soc term - synergistic is the key word
10. There is nothing suspicious about my company carrying out a string of small, single-arm studies over ~ a decade that prove nothing regarding efficacy. maybe they learned something during the last decade - dont bother to follow them
11. If the stock goes up, that's a good sign. If it shows weakness, it should probably be sold. [See post #120060!] i guess you dont have a sale strategy...i should explain to you if and when i sell a stock
